Vol 2019, No 6 (2019)

Table of Contents

Research & Development

Bayer Latest to Join Protein Degrader Space with Arvinas Collaboration Abstract pdf html
Michelle Liu
Janssen Collaborates with Genmab For HexaBody-CD38 Abstract html pdf
Jasmine Kalsi & Michelle Liu
Gilead Joins Growingly Crowded Protein Degradation Field with Nurix Therapeutics Deal Abstract pdf html
Michelle Liu

Mergers & Acquisitions

Vertex Expands Gene Therapy Footprint with CRISPR Therapeutics and Exonics Deals Abstract pdf html
Michelle Liu
Merck & Co. Bolsters Oncology Pipeline with US$773 M Acquisition of Tilos Therapeutics Abstract pdf html
Sharath Chandra Nakka & Michelle Liu
Pfizer to Acquire Array BioPharma for Colorectal Cancer Combo Abstract pdf html
Michelle Liu


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.